KAINOS MEDICINE (284620) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, KAINOS MEDICINE (284620) reported revenue of 1.2 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
20251.2 billion KRW-6.4 billion KRW-7.8 billion KRW[source]
2024590 million KRW-12.3 billion KRW-12.2 billion KRW[source]
2023267 million KRW-16.8 billion KRW-15.2 billion KRW[source]
2022130 million KRW-16.2 billion KRW-15.9 billion KRW[source]
20211.7 billion KRW-11.2 billion KRW-16.2 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
20255.5 billion KRW613 million KRW4.9 billion KRW[source]
20249.3 billion KRW1.9 billion KRW7.5 billion KRW[source]
202318.7 billion KRW3.7 billion KRW15.0 billion KRW[source]
202234.0 billion KRW7.9 billion KRW26.1 billion KRW[source]
202135.7 billion KRW23.6 billion KRW12.1 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice